|
|
|
|
| LEADER |
01498nam a2200277 u 4500 |
| 001 |
EB000944206 |
| 003 |
EBX01000000000000000737796 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 245 |
0 |
0 |
|a Ingenol mebutate (Picato)
|h Elektronische Ressource
|b topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2014, 2014
|
| 300 |
|
|
|a 1 online resource
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Diterpenes / therapeutic use
|
| 653 |
|
|
|a Keratosis, Actinic / drug therapy
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Administration, Topical
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Common drug review clinical review report
|
| 500 |
|
|
|a Title from title screen. - "February 2014."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK195596
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The objective of this systematic review is to examine the beneficial and harmful effects of ingenol mebutate once daily for the topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (AK) for the face and scalp (0.015% gel, three-day treatment) and for the trunk and extremities (0.05% gel, two-day treatment) in adult patients
|